Dear All,
I have completed recon-all on my dataset of controls and patients. My patients have hippocampal/MTL atrophy and I would like to conduct multiple comparisons on the data to ensure that the atrophy is indeed focal in each patient and if not, identify where else atrophy is occurring in these patients. My hypothesis is that I do not expect atrophy elsewhere due to the disease type of these patients, but as this has never been confirmed outside of visual inspection before I wish to check this more robustly.
I am not at all familiar with this kind of analysis and would like to ask some advice on how I should approach this? My initial instinct is to go with permutation testing. I would like to consider the whole brain (subcortical and surface).
Are there other issues I should be taking into account?
Any advice and specific information regarding the subsequent analysis in freesurfer would be greatly appreciated.
Many thanks in advance.
Clare
Hi Clare,
This is something that PALM http://fsl.fmrib.ox.ac.uk/fsl/fslwiki/PALM can do. It seems we're in the same Dept. Please send me an email off-list and we can try to have this sorted out.
All the best,
Anderson
On 19 November 2015 at 08:37, Clare Loane clare.loane@ndcn.ox.ac.uk wrote:
Dear All,
I have completed recon-all on my dataset of controls and patients. My patients have hippocampal/MTL atrophy and I would like to conduct multiple comparisons on the data to ensure that the atrophy is indeed focal in each patient and if not, identify where else atrophy is occurring in these patients. My hypothesis is that I do not expect atrophy elsewhere due to the disease type of these patients, but as this has never been confirmed outside of visual inspection before I wish to check this more robustly.
I am not at all familiar with this kind of analysis and would like to ask some advice on how I should approach this? My initial instinct is to go with permutation testing. I would like to consider the whole brain (subcortical and surface).
Are there other issues I should be taking into account?
Any advice and specific information regarding the subsequent analysis in freesurfer would be greatly appreciated.
Many thanks in advance.
Clare
Freesurfer mailing list Freesurfer@nmr.mgh.harvard.edu https://mail.nmr.mgh.harvard.edu/mailman/listinfo/freesurfer
The information in this e-mail is intended only for the person to whom it is addressed. If you believe this e-mail was sent to you in error and the e-mail contains patient information, please contact the Partners Compliance HelpLine at http://www.partners.org/complianceline . If the e-mail was sent to you in error but does not contain patient information, please contact the sender and properly dispose of the e-mail.
freesurfer@nmr.mgh.harvard.edu